Navigation Links
Fate Therapeutics Initiates Phase 2 Clinical Study of ProHema for the Treatment of Hematologic Malignancies
Date:11/27/2012

SAN DIEGO, Nov. 27, 2012 /PRNewswire/ -- Fate Therapeutics, Inc., a biopharmaceutical company engaged in the discovery and development of adult stem cell modulators, announced today the initiation of a randomized, controlled, Phase 2 multi-center study of its investigational hematopoietic stem cell therapy, ProHema, in adult patients undergoing double umbilical cord blood transplantation (dUCBT) for hematologic malignancy.  The advancement of ProHema into later-stage development builds upon positive results from a Phase 1b single-center study, interactions with the U.S. Food and Drug Administration and refinements to the product manufacturing process.  The previously completed Phase 1b study achieved its primary objective of demonstrating safety and tolerability.  The study also established early clinical proof-of-concept – trends of accelerated neutrophil recovery, improved 100-day survival and low rates of graft-versus-host disease were evident, and durable and preferential reconstitution with ProHema occurred in 10 of 12 evaluable patients.  ProHema is produced through a proprietary, two-hour, ex vivo modulation process, which has been shown to significantly activate key biological pathways involved in hematopoietic stem cell homing, proliferation and survival in preclinical models.

"Allogeneic umbilical cord blood transplantation holds great promise as a potentially curative treatment for children and adults with hematologic malignancies and many other life-threatening, non-malignant disorders," said Christian Weyer, M.D., M.A.S., President and Chief Executive Officer of Fate Therapeutics.  "ProHema is being developed with the intent to improve outcomes in patients undergoing cord blood transplantation by facilitating both accelerated engraftment and durable reconstitution using a simple, point-of-care, ex vivo modulation process. The initiation of Phase 2 marks an important milestone for the company and bri
'/>"/>

SOURCE Fate Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Epizyme Publishes Current Review on Targeting Protein Methyltransferases for Personalized Cancer Therapeutics
2. MabVax Therapeutics Closes $5.25 Million Financing with Numoda Capital Innovations, Burrill Capital Fund IV, and RTP Venture Fund
3. Cystic Fibrosis Foundation Therapeutics Announces $58 Million CF Drug Discovery Agreement with Pfizer
4. Echo Therapeutics Hires Daniel Sunday as Vice President of Manufacturing and Global Supply Chain
5. Caliber and ImmunGene Launch Valor Biotherapeutics, a Joint Venture to Develop Antibody-Interferon Fusion Therapeutics to Treat Cancers
6. Echo Therapeutics Chosen to Present at the 12th Annual Diabetes Technology Meeting
7. Immunomic Therapeutics Begins Phase I Japanese Red Cedar JRC-LAMP-Vax Vaccine Safety Study
8. Stemline Therapeutics Lead Clinical Candidate SL-401 Induces a Complete Response in a Patient with a Drug-Refractory Plasmacytoid Dendritic Cell Neoplasm
9. Echo Therapeutics Announces Third Quarter 2012 Financial Results
10. Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
11. Particle Sciences Develops Novel Ocular Formulation for Eyeon Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 28, 2015  Perrigo Company plc ("Perrigo") (NYSE: ... the acquisition of leading OTC brands from GSK in ... transaction is a clear demonstration of Perrigo,s unique ability ... distribution network spanning 36 countries.  Perrigo ... commented, "We are excited to complete this transaction, which ...
(Date:8/28/2015)... LONDRES, 28 de agosto de 2015   ... su participación en el  Congreso de la ESC ... más recientes y novedosas, entre ellas HeartModel A.I. ... las personas y la tecnología con los protocolos ... guiar los tratamientos y permitir atención en el ...
(Date:8/27/2015)... 27, 2015 DURECT Corporation (Nasdaq: DRRX ... at three upcoming healthcare conferences.  , ... present at the Rodman & Renshaw Investment Conference on ... conference is being held at the St. Regis Hotel ... live audio webcast of the presentation will be available ...
Breaking Medicine Technology:Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5DURECT to Participate in Upcoming Healthcare Conferences 2
... 2011 The Consumer Healthcare Products Association (CHPA) ... North Carolina legislature passing a real-time, stop-sale system ... effective medicines containing pseudoephedrine (PSE), while stopping sales ... passage of a real-time, stop-sale system is a ...
... 2011 SmallCapVoice.com, Inc. announced today that ... Medical Equipment, Inc. (Pinksheets: SHOM), a holding ... durable medical equipment to medical institutions, is ... at http://smallcapvoice.com/blog/6-14-11-audio-interview-with-southern-home-medical-equipment-inc-pink-sheets-shom . SmallCapVoice ...
Cached Medicine Technology:A New Audio Interview With Jerry Overcash, Director for Southern Home Medical Equipment, Inc., is now at SmallCapVoice.com 2A New Audio Interview With Jerry Overcash, Director for Southern Home Medical Equipment, Inc., is now at SmallCapVoice.com 3
(Date:8/31/2015)... ... August 31, 2015 , ... healthbeautydistributors.com has been in ... test marketing a doctor note service to be made available to all patients ... for each generated excuse, much less than the average daily pay of workers. ...
(Date:8/30/2015)... ... August 31, 2015 , ... Avid collector Andrew Hawley from Vintage Rock Posters ... posters. This hand colored artwork is one of the most coveted Doors concert posters. ... "When the doors played the Shrine, the band was one of the biggest ...
(Date:8/30/2015)... ... 2015 , ... ChopChop Kids, the nonprofit publisher of the ... two new officers to serve on the organization’s Board of Directors in accordance ... kids to cook real food with their families and help continue to drive ...
(Date:8/30/2015)... ... ... Scientists in France say asbestos exposure may put workers at higher risk ... just posted an article on the new research. Click here to read it ... 2,024 French asbestos plant workers from 1978 to 2009. In addition to mesothelioma, the ...
(Date:8/30/2015)... Boca Raton, Fl (PRWEB) , ... August 30, ... ... today that Kathleen Kall has been promoted from Administrative assistant to Executive Assistant ... communication, you’ll interact with a proven professional, focused on your goals. Kathleen ...
Breaking Medicine News(10 mins):Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 2Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 3Health News:Researchers Say Mesothelioma Not the Only Cancer Linked with Asbestos Exposure, According to Surviving Mesothelioma 2Health News:NPI Appoints New Executive Assistant To CEO 2
... releases new study of Medigap market, WASHINGTON, ... (Medigap) challenges previous,assumptions about Medigap,s impact on Medicare ... (AHIP) was published this week in the,journal Health ... the Medigap,market which found that Medigap enrollment has ...
... Diabetes and,hypertension are the two leading risk factors ... two-thirds of cases. Yet a new study that ... Clinical Meeting next,month indicates there is wide discrepancy ... these conditions, with patients with high blood,pressure (hypertension) ...
... East Bay Healthcare Executive, OAKLAND, Calif., March 12 ... D. Siljestrom to lead,one of the nation,s largest non-profit ... CEO of East Bay Integrated Care and,executive vice president ... Hill, Calif., begins her new position on April 14, ...
... food, more fruits and vegetables , , WEDNESDAY, March 12 ... instilled healthy eating habits in children aged 2 to ... researchers at the University of Miami Miller School of ... went to eight subsidized child-care centers in Miami Dade ...
... following,is being issued by Foundation for Taxpayer and Consumer ... out against proposed legislation that,would create a loophole in ... without a patient,s consent. The bill, SB 1096,(Calderon), does ... be,necessary to provide health care services. Transfers of private ...
... Pa., March 12 Four,Rivers Software Systems, a ... the healthcare industry and ECRI Institute,an independent nonprofit ... announce the availability of new, real-time interfaces for,their ... This new integration offers hospitals new ...
Cached Medicine News:Health News:New AHIP Study in Health Affairs Challenges Previous Assumptions About Medigap's Impact on Medicare Costs 2Health News:New AHIP Study in Health Affairs Challenges Previous Assumptions About Medigap's Impact on Medicare Costs 3Health News:Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds 2Health News:Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds 3Health News:Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds 4Health News:Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds 5Health News:Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds 6Health News:Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds 7Health News:Transplant Network Appoints Cynthia Siljestrom CEO 2Health News:Preschool Intervention Curbed Trend Toward Obesity 2Health News:Preschool Intervention Curbed Trend Toward Obesity 3Health News:Four Rivers Software Systems and ECRI Institute Announce New, Real-Time Interfaces to Improve Inventory Management and Patient Safety Alert and Recall Tracking 2Health News:Four Rivers Software Systems and ECRI Institute Announce New, Real-Time Interfaces to Improve Inventory Management and Patient Safety Alert and Recall Tracking 3
Immuno-turbidimetric Assay for Antithrombin III Antigen. Suspension of microlatex particles coated with specific antibodies....
Immuno-turbidimetric assay for Free Protein Sby STA© Analyzers. Suspension of microparticles coated with monoclonal antibodies to Free Protein S....
Substrate Plasma for Factor II Assay by STA© Analyzers. Freeze-dried human serum and absorbed bovine plasma, the latter providing factor V and fibrinogen to the test system....
Substrate Plasma for Factor VIII Assay by STA© Analyzers. Freeze-dried human plasma from which factor VIII has been removed by selective immuno-adsorption....
Medicine Products: